Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
‘Softe uitkomsten kunnen “harde” consequenties hebben voor patiënten’
dec 2022 | Epilepsie, Neuro-musculair, Neuro-oncologie, Neuro-vasculair